Pharmaceutical

Novartis reports 7% rise in Q2 2023 net sales

Novartis has reported net sales of $13.62bn in Q2 of 2023, indicating a 7% rise compared to $12.78bn in the same quarter of 2022.

Jul 19, 2023 - 20:00
Novartis reports 7% rise in Q2 2023 net sales
Novartis has reported net sales of $13.62bn in Q2 of 2023, indicating a 7% rise compared to $12.78bn in the same quarter of 2022.
Read the original article

Tags:

Previous Article

Santhera and Catalyst to market DMD drug vamorolone in North America

Next Article

Advent receives US NIH grant for bronchopulmonary dysplasia therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Democrats decry a new health package as too easy on private equity

STAT+: Democrats decry a new health package as too easy...

Jul 26, 2023

STAT+: Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

STAT+: Bipartisan group of lawmakers warns of a rising ...

Feb 17, 2024

STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs

STAT+: Pharmalittle: Woodcock to retire from the FDA; A...

Nov 17, 2023